Kitolak

Ciclopirox, the active ingredient in Kitolak, is an antifungal presented as a topical formulation for skin application. It is used to treat fungal infections of the skin and nails in adults and children when appropriate. GNH USA supplies Kitolak as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ciclopirox is an antifungal that targets dermatophyte and yeast infections of the skin. - Tinea pedis: reduces itching, scaling and erythema caused by athlete's foot. - Tinea corporis: clears ring‑shaped lesions and prevents spread of the infection. - Candidiasis: treats cutaneous candidal eruptions, relieving redness and discomfort. - Dermatophytosis: eliminates fungal colonies on the skin, promoting healing and preventing recurrence.

Ciclopirox may cause local skin reactions.

Common Side Effects: - Itching: mild to moderate sensation at the application site. - Burning: transient heat sensation after application. - Redness: localized erythema. - Dryness: skin may feel less moist. - Irritation: mild discomfort or stinging. - Scaling: flaking of the treated area.

Serious or Rare Side Effects: - Allergic reaction: hives, swelling, or difficulty breathing. - Severe dermatitis: extensive redness, blistering, or oozing. - Swelling: localized edema at the site. - Blistering: formation of fluid‑filled lesions. - Contact urticaria: rapid wheal formation after contact. - Systemic toxicity: rare liver enzyme abnormalities with extensive use.

Ciclopirox should be used with care to minimise adverse reactions. - Avoid application on broken or inflamed skin: may increase irritation. - Discontinue if severe redness or swelling occurs: seek medical advice. - Keep away from eyes and mucous membranes: avoid accidental contact. - Do not use on children under 2 years unless directed: safety not established. - Do not cover with occlusive dressings unless instructed: may enhance absorption. - Store at room temperature below 25°C: keep in the original pack, protect from moisture.

Ciclopirox can interact with other topical agents and systemic medications.

Major Interactions (Avoid): - Concurrent use with other topical antifungals: may increase local irritation. - Combination with potent corticosteroids: may reduce antifungal efficacy. - Application with photosensitizing agents: heightened risk of phototoxic reactions.

Moderate Interactions (Monitor Closely): - Use alongside systemic antifungals: monitor for additive systemic exposure. - Co‑application with skin irritants (e.g., harsh soaps): may exacerbate dermatitis. - Use with alcohol‑based cleansers: can increase drying and irritation.